1. Home
  2. ICFI vs ANIP Comparison

ICFI vs ANIP Comparison

Compare ICFI & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$69.08

Market Cap

1.8B

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$79.20

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICFI
ANIP
Founded
1969
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2006
1999

Fundamental Metrics

Financial Performance
Metric
ICFI
ANIP
Price
$69.08
$79.20
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$99.25
$110.00
AVG Volume (30 Days)
381.0K
330.9K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
0.82%
N/A
EPS Growth
N/A
419.23
EPS
1.12
1.28
Revenue
$1,229,162,000.00
$206,547,000.00
Revenue This Year
$4.12
$21.01
Revenue Next Year
$5.33
$17.59
P/E Ratio
$61.72
$63.35
Revenue Growth
3.72
2.47
52 Week Low
$58.83
$58.70
52 Week High
$101.71
$99.50

Technical Indicators

Market Signals
Indicator
ICFI
ANIP
Relative Strength Index (RSI) 53.01 45.94
Support Level $64.43 $77.03
Resistance Level $75.03 $83.58
Average True Range (ATR) 3.10 2.65
MACD 0.46 -0.21
Stochastic Oscillator 78.89 38.47

Price Performance

Historical Comparison
ICFI
ANIP

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: